Joseph Romanelli - Apr 30, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, Human Health Int?l
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Stock symbol
MRK
Transactions as of
Apr 30, 2024
Transactions value $
$147,734
Form type
4
Date filed
5/2/2024, 04:29 PM
Previous filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $291K +2.26K +11.56% $128.80 21.8K May 2, 2024 Direct
transaction MRK Common Stock Tax liability -$144K -1.12K -5.11% $128.80 20.7K May 2, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +6.19K $0.00 6.19K Apr 30, 2024 Common Stock 6.19K Direct F1, F2
transaction MRK Stock Option (Right to Buy) Award $0 +23.4K $0.00 23.4K Apr 30, 2024 Common Stock 23.4K $129.22 Direct F3
transaction MRK Restricted Stock Unit Options Exercise $0 -2.26K -33.33% $0.00 4.52K May 2, 2024 Common Stock 2.26K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F3 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F4 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.